Gestational Hyperglycemia
Conditions
Interventions
Experimental Group (Prospective):Wear a non-invasive sweat sensor (automatically collects blood glucose, fetal movement, and maternal activity data every 10 minutes).
Control group (Prospective):Conventional fingertip blood sampling monitoring (7 times daily)
Observation Group (Retrospective):None
Sponsors
Xiamen Maternal and Child Care Hospital
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: 1. Retrospective section: Singleton pregnant women diagnosed with gestational diabetes mellitus (GDM) at Xiamen Maternal and Child Health Hospital from January 2024 to December 2024; Complete record of blood glucose and lipid data during pregnancy and delivery outcomes (such as macrosomia, cesarean section, neonatal hypoglycemia). 2. Prospective part: Singleton pregnancy, aged 18-40 years; GDM was diagnosed before 24 weeks of pregnancy. No history of skin allergies or contraindications for wearing sensors; Voluntarily sign the informed consent form and agree to random grouping.
Exclusion criteria
Exclusion criteria: 1. Retrospective section: Complicated with severe pregnancy complications (such as preeclampsia, placental abruption); Cases with data missing by more than 30%. 2. Prospective section: Multiple pregnancies or conception through assisted reproductive technology; Had been diagnosed with type 1 or type 2 diabetes before pregnancy; There are severe liver and kidney function abnormalities or other metabolic diseases; Plan to transfer to another hospital halfway or fail to complete the follow-up.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Glucose concentration in sweat;Fingertip blood glucose value; | — |
Countries
China
Contacts
Public ContactHuang Llingling
Xiamen Maternal and Child Care Hospital
Outcome results
None listed